Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SUNRISE, Fla., Oct. 17, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc., (Nasdaq:BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure...
-
SUNRISE, Fla., Oct. 17, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) today announced that it received a letter from the Nasdaq Stock Market (the "Nasdaq Letter") on October 15, 2008 advising...
-
SUNRISE, Fla., Feb. 19, 2008 (PRIME NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today the pricing of its initial public offering of 1,100,000 shares of common stock at a price of $5.25 per...
-
SUNRISE, Fla., March 7, 2007 (PRIME NEWSWIRE) -- Bioheart, Inc., a biotechnology company focused on the discovery, development and commercialization of cell-based therapies and related devices, for...
-
SUNRISE, Fla. and CLEVELAND, Feb. 26, 2007 (PRIME NEWSWIRE) -- Bioheart, Inc., a biotechnology company focused on the development of innovative cell therapies for the treatment of heart attacks,...